Relmada Therapeutics Inc. (RLMD)
0.26
0.00 (0.00%)
At close: Mar 03, 2025, 3:59 PM
0.24
-5.22%
After-hours: Mar 03, 2025, 06:03 PM EST
Relmada Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -98.79M | -157.04M | -125.75M | -59.46M | -15.01K | -17.32M | -8.96M | -6.29M | -2.97M | -20.8M | -45.02K | -12.05K |
| Depreciation & Amortization | n/a | n/a | 1.26K | 3.75K | 4.36 | 4.87K | 2.63K | 85.27K | 54.82K | 9.26K | 250.00 | n/a |
| Stock-Based Compensation | 43.81M | 44.19M | 40.49M | 20.78M | 2.76K | 1.21M | 518K | 704.45K | 1.21M | 796.95K | 14.48K | n/a |
| Other Working Capital | 4.32M | 10.17M | -10.71M | 3.03M | -26.46 | 1.35M | 542.67K | 482.46K | 1.25M | -1.21M | 3.17K | -3K |
| Other Non-Cash Items | 241.31K | -1.55M | 1.25M | 16.95K | 172.81 | 266.76K | 1.03M | -721.84K | -13.11M | 4.89M | 10.15K | n/a |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 3.83M | 708.9K | -620.25K | -13.31M | 3.71M | n/a | n/a |
| Change in Working Capital | 3.08M | 10.59M | -7.86M | 10.85M | -26.46 | 1.51M | 700.06K | -247.69K | 1.68M | -1.12M | 32.91K | 4.49K |
| Operating Cash Flow | -51.66M | -103.8M | -91.87M | -27.81M | -12.09K | -10.5M | -6M | -6.47M | -13.14M | -16.23M | -11.86K | -7.57K |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -12.39K | -49.69K | -562.26K | -23.33K | -1.8K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -90.46M | -47.29M | -222.98M | -182.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 140.92M | 67.03M | 168.86M | 147.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 19.73K | -54.12K | -34.45K | -80.16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 50.45M | 19.73M | -54.12M | -34.45M | -80.16K | n/a | -12.39K | -49.69K | -562.26K | -23.33K | -1.8K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | -285.17K | 6.54M | -273.67K | -263.75K | -293.63K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -98.46K | 2.29M | 2.63M | 28.47M | 126.11K | n/a | n/a | n/a | n/a | 13.45M | n/a | n/a |
| Financial Cash Flow | -98.46K | 45.02M | 187.94M | 28.47M | 126.11K | 17.48M | 6.54M | -273.67K | -263.75K | 13.16M | 20K | 13.5K |
| Net Cash Flow | -1.3M | -39.05M | 41.95M | -33.78M | 6.98K | 6.98M | 528.43K | -6.79M | -13.97M | -3.09M | 6.34K | 5.93K |
| Free Cash Flow | -51.66M | -103.8M | -91.87M | -27.81M | -12.09K | -10.5M | -6.01M | -6.52M | -13.71M | -16.25M | -13.66K | -7.57K |